Education
Ph.D in Chemical Engineering, Yonsei University, 1999
Current position
Senior Research Fellow, CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford
Publications (since 2010)
-
Reymond, N., Im, J. H., Garg, R., Cox, S., Soyer, M., Riou, P., Colomba, A., Muschel, R. J. and Ridley, A. J. (2015). RhoC and ROCKs regulate cancer cell interactions with endothelial cells. Mol Oncol 9(6): 1043-1055.
-
Im, J. H., Tapmeier, T., Balathasan, L., Gal, A., Yameen, S., Hill, S., Smart, S., Noterdaeme, O., Kelly, M., Brady, M., Fu, W., Kruse, K., Bernhard, E. J., Augustin, H. G. and Muschel, R. J. (2013). G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency. Int J Cancer 132(2): 315-326.
-
Zhao, L., Lim, S. Y., Gordon-Weeks, A. N., Tapmeier, T. T., Im, J. H., Cao, Y., Beech, J., Allen, D., Smart, S. and Muschel, R. J. (2013). Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis. Hepatology 57(2): 829-839.
-
Lim, S. Y., Gordon-Weeks, A. N., Zhao, L., Tapmeier, T. T., Im, J. H., Cao, Y., Beech, J., Allen, D., Smart, S. and Muschel, R. J. (2013). Recruitment of myeloid cells to the tumor microenvironment supports liver metastasis. Oncoimmunology 2(3): e23187.
-
Im, J. H. and Muschel, R. J. (2012). New evidence of lncRNA role in tumor progression and metastasis. Hepatobiliary Surg Nutr 1(1): 55-56.
-
Reymond, N., Im, J. H., Garg, R., Vega, F. M., Borda d'Agua, B., Riou, P., Cox, S., Valderrama, F., Muschel, R. J. and Ridley, A. J. (2012). Cdc42 promotes transendothelial migration of cancer cells through beta1 integrin. J Cell Biol 199(4): 653-668.
-
Gil-Bernabe, A. M., Ferjancic, S., Tlalka, M., Zhao, L., Allen, P. D., Im, J. H., Watson, K., Hill, S. A., Amirkhosravi, A., Francis, J. L., Pollard, J. W., Ruf, W. and Muschel, R. J. (2012). Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. Blood 119(13): 3164-3175.
-
Fokas, E., Im, J. H., Hill, S., Yameen, S., Stratford, M., Beech, J., Hackl, W., Maira, S. M., Bernhard, E. J., McKenna, W. G. and Muschel, R. J. (2012). Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature. Cancer Res 72(1): 239-248.
-
Qayum, N., Im, J., Stratford, M. R., Bernhard, E. J., McKenna, W. G. and Muschel, R. J. (2012). Modulation of the tumor microvasculature by phosphoinositide-3 kinase inhibition increases doxorubicin delivery in vivo. Clin Cancer Res 18(1): 161-169.
-
Liu, S. K., Bham, S. A., Fokas, E., Beech, J., Im, J., Cho, S., Harris, A. L. and Muschel, R. J. (2011). Delta-like ligand 4-notch blockade and tumor radiation response. J Natl Cancer Inst 103(23): 1778-1798.